Cary is a partner at Third Rock Ventures and has more than 20 years of business development and transaction experience, along with a broad array of biotech product development experience. Cary has played an instrumental role in the development of a number of innovative alliances and collaborative company building efforts across Third Rock’s portfolio, including an industry-leading global strategic collaboration between Agios and Celgene in the field of cancer metabolism. He currently serves on the Board of Directors of Jounce Therapeutics, Neon Therapeutics (as Chairman), and Tango Therapeutics.
Before joining Third Rock, Cary founded The Pfeffer Group, a boutique consulting firm that provided business development and strategy advisory services, completing multiple transactions for leading biotechnology and life sciences companies. Prior to that, Cary spent more than a decade at Biogen where he held a variety of senior and executive level management roles focused on U.S. and global business and market development, product development and commercial operations. Earlier in his career, Cary spent several years in corporate finance in the Health Care Investment Banking Group of Lehman Brothers. He earned his M.D. from the University of Pennsylvania, his MBA from the Wharton School of the University of Pennsylvania and holds a B.A. in biochemistry from Columbia University.